Articles From: iCAD Promotes CFO Kevin Burns to Chief Operating Officer to Icahn calls PayPal IPO idea one of "pragmatism"


iCAD, Inc. (Nasdaq:ICAD), industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that Chief Financial Officer (CFO), Kevin Burns, has been named iCAD’s Chief Operating Officer (COO). In this newly-created position, Burns will lead and manage all operational functions within the Company in addition to continuing his role as CFO.
Sign-up for iCAD Promotes CFO Kevin Burns to Chief Operating Officer investment picks
2014/2/19
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and twelve months ended December 31, 2013.
Sign-up for iCAD Reports 2013 Fourth Quarter and Full Year Financial Results investment picks
iCAD, Inc. (Nasdaq: ICAD), a leading provider of advanced imaging and radiation therapy for the early identification and treatment of cancer, today announced growing demand, adoption and clinical evidence for its Xoft® Axxent® Electronic Brachytherapy System® for the treatment of early-stage breast cancer and non-melanoma skin cancer .
Sign-up for iCAD Reports Growing Adoption and Utilization of Its Xoft System for Breast and Skin Cancers investment picks
2013/10/28
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the three and nine months ended September 30, 2013.
Sign-up for iCAD Reports Third Quarter Financial Results investment picks
2014/2/7
iCAD, Inc. (Nasdaq: ICAD) , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today announced that the Company will release financial results for the three and 12 months ended December 31, 2013, following the close of the market on Wednesday, February 19, 2014.
Sign-up for iCAD to Host 2013 Fourth Quarter and Full Year Financial Results Conference Call on Thursday, February 20, 2014 investment picks
2013/10/22
iCAD, Inc. (Nasdaq: ICAD) , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will release financial results for the three and nine months ended September 30, 2013, following the close of the market on Monday, October 28, 2013.
Sign-up for iCAD to Host Third Quarter Financial Results Conference Call on Tuesday, October 29, 2013 investment picks
iCAD, Inc. (Nasdaq: ICAD) , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announces that Company management will participate in the 16th Annual Needham Growth Conference being held January 14-16, 2014 at the New York Palace Hotel in New York City.
Sign-up for iCAD to Participate in the 16th Annual Needham Growth Conference investment picks
iCAD, Inc. (Nasdaq: ICAD) , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announces that Company management will participate in the Canaccord Genuity Medical Technology & Diagnostics Forum being held November 14, 2013 at The Westin New York Grand Central.
Sign-up for iCAD to Participate in the Canaccord Genuity Medical Technology & Diagnostics Forum investment picks
2013/11/26
iCAD, Inc. (Nasdaq: ICAD) , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announces that Company management will participate in the LD Micro Conference being held December 3-5, 2013 at the Luxe Sunset Bel Air Hotel in Los Angeles.
Sign-up for iCAD to Participate in the LD Micro Conference investment picks
2014/2/21
iCAD, Inc. (Nasdaq: ICAD) , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today announced that Company management will participate in the 2014 RBC Capital Markets' Global Healthcare Conference taking place from February 25-26, 2014 at the New York Palace Hotel.
Sign-up for iCAD to Present at the 2014 RBC Capital Markets' Global Healthcare Conference investment picks
2013/11/26
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will showcase its suite of Computer-Aided Detection (CAD) and advanced imaging solutions at the Radiological Society of North America (RSNA) 99 th Annual Meeting being held December 1-6, 2013 in Chicago.
Sign-up for iCAD to Showcase Its Platform of Computer-Aided Detection and Advanced Imaging Solutions at RSNA Annual Meeting investment picks
2014/3/17
iCAD, Inc. (“iCAD”) (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy solutions for the early identification and treatment of cancer, today announced it has closed its previously-announced registered firm commitment underwritten public offering of 2,760,000 shares at a price to the public of $11.00 per share.
Sign-up for iCAD, Inc. Announces Closing of Underwritten Public Offering of Common Stock investment picks
2014/3/12
iCAD, Inc. (“iCAD”) (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy solutions for the early identification and treatment of cancer, today announced it has priced a registered firm commitment underwritten public offering of 2,400,000 shares of its common stock at a price to public of $11.00 per share.
Sign-up for iCAD, Inc. Announces Pricing of 2,400,000 Share Public Offering of Common Stock investment picks
2014/3/5
iCAD, Inc. (“iCAD”) (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy solutions for the early identification and treatment of cancer, today announced that it intends to offer 2,000,000 shares of its common stock in a firm commitment underwritten public offering, subject to market and other conditions.
Sign-up for iCAD, Inc. Announces Proposed Public Offering of Common Stock investment picks
2013/10/7
Carl Icahn has acquired a nearly 6% stake in oil and gas producer Talisman Energy Inc. (TLM, TLM.T), a move the activist investor said may lead to conversations with management about board seats and strategic alternatives.
Sign-up for Icahn Acquires Nearly 6% Stake in Talisman Energy investment picks
2013/10/7
By John Kell Carl Icahn has acquired a nearly 6% stake in oil and gas producer Talisman Energy Inc. (TLM, TLM.T), a move the activist investor said may lead to conversations with management about board seats and strategic alternatives.
Sign-up for Icahn Acquires Nearly 6% Stake in Talisman Energy; Shares Jump investment picks
2013/11/15
DJ CFA SOURCE: SEC 13F-HR FILER: Icahn Associates Corp.
Sign-up for Icahn Associates Corp. 3Q 13F: Holdings As Of Sep 30 investment picks
DJ CFA SOURCE: SEC 13F-HR FILER: Icahn Associates Corp.
Sign-up for Icahn Associates Corp. 3Q 13F: Largest Purchases investment picks
NEW YORK (MarketWatch) -- Carl Icahn hammered into the governance structure of Dell Inc. (DELL) on Monday in an interview with CNBC.
Sign-up for Icahn bashes Dell governance, praises Apple investment picks
Activist investor Carl Icahn on Wednesday said eBay Inc. (EBAY) unit PayPal would be better served with different management from eBay.
Sign-up for Icahn Believes a PayPal Spinoff From eBay Is 'a No-Brainer' -Bloomberg TV investment picks
2014/2/14
SAN FRANCISCO (MarketWatch) -- Carl Icahn's stake in Apple Inc. (AAPL) rose during the last three months of 2013 to 4.7 million shares, according to his latest holdings report filed with the SEC Friday.
Sign-up for Icahn boosts Apple stake, trims Netflix per 13F investment picks
Activist investor Carl Icahn reported slightly increased holdings in Nuance Communications Inc. (NUAN) as of Dec.
Sign-up for Icahn Boosts Stake in Nuance Communications investment picks
2014/1/28
NEW YORK (MarketWatch) -- Carl Icahn added $500 million more to his stockpile Apple Inc. (AAPL) shares, the activist investor said via Twitter Tuesday.
Sign-up for Icahn buys $500 mln more of Apple shares investment picks
2014/1/23
SAN FRANCISCO (MarketWatch) - Billionaire investor Carl Icahn on Thursday said he bought another $500 million in Apple Inc. (AAPL) shares, as he called the company board's refusal to increase the size of its stock buyback plan a "great disservice," especially to smaller shareholders "who may not be in a position to buy more stock themselves." Icahn made the argument in a letter to Apple shareholders, as part of his campaign to convince Apple to boost its buyback program by an additional $50 billion.
Sign-up for Icahn buys another $500 million in Apple shares investment picks
2014/3/5
SAN FRANCISCO (MarketWatch) -- The war of words between activist investor Carl Icahn and eBay Inc. (EBAY) flared again Wednesday as Icahn said he has "never seen worse corporate governance than eBay." Icahn, who owns about 2% of eBay's stock, made his latest comments about eBay in an interview Wednesday on CNBC.
Sign-up for Icahn calls eBay worst-governed company he's seen investment picks
Activist investor Carl C.
Sign-up for Icahn Calls for eBay to Split investment picks
2014/1/22
By Michael Calia Activist investor Carl C.
Sign-up for Icahn Calls for Spinoff of PayPal From eBay investment picks
2014/3/24
SAN FRANCISCO (MarketWatch) -- Activist investor Carl Icahn on Monday described his call for eBay Inc. (EBAY) to as one of "pragmatism" after discussion he said he's had with many eBay shareholders.
Sign-up for Icahn calls PayPal IPO idea one of "pragmatism" investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: iCAD Promotes CFO Kevin Burns to Chief Operating Officer to Icahn calls PayPal IPO idea one of "pragmatism"
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity